(E)-4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-en-2-ol, 97%, 5g

tert-Butyl 2-(2-(2-(prop-2-yn-1-yloxy)ethoxy)ethoxy)acetate, 500mg

N-(2-furylmethyl)-4,7-dimethyl-1,3-benzothiazol-2-amine, 95.0%, 500mg

6-Iodo-1,1,4,4-tetramethyl-1,2,3,4-tetrahydronaphthalene, 95%, 5g

Pd- Dihydrogentetrachloropalladate(II), solution 5 g

RuPhos Pd G3, >98.0%, 1g

tert-Butyl 4-(Aminocarbothioyl)tetrahydropyridine-1(2H)-carboxylate, 95.0%, 500g

N1,N2-Dimethylcyclohexane-1,2-diamine hydrochloride, 95.0%, 25g

4'-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-methyl benzophenone, 97.0%, 1g

Ethyl 6-aminoimidazo[1,2-a]pyridine-2-carboxylate, 95.0%, 1g

6-Methoxyflavone>99.0%(GC)1g

Ethyl 6-bromopyrazolo[1,5-a]pyridine-3-carboxylate, 95.0%, 1g

2-methyl-1H-benzimidazol-4-ol, 95.0%, 1g